(SOURCE: JAMA/Archives journals, news release, Dec. 3, 2007)
MONDAY, Dec. 3 (HealthDay News) -- There's no link between vaccination to protect against hepatitis B and the risk of developing multiple sclerosis (MS) in childhood, a new study finds.
A number of previous studies have investigated a possible association between the hepatitis B vaccine and MS in adults and most found no evidence of increased short- or long-term risk of MS. However, the studies were criticized for problems with their methodology, including how participants' vaccination status was confirmed. This controversy created public doubts about the hepatitis B vaccine, according to background information in the study.
In this new study, French researchers compared 143 children who developed MS before age 16 with a control group of 1,122 age- and sex-matched MS-free participants in the general population.
About 32 percent of both the MS patients and the control group participants had received the hepatitis B vaccine.
Vaccination against hepatitis B within the three-year study period was not associated with an increased rate of a first episode of MS. "The rate was also not increased for hepatitis B vaccination within six months of the index date or any time since birth or as a function of the number of injections or the brand of hepatitis B vaccine," the study authors wrote.
"Vaccination against hepatitis B does not seem to increase the risk of a first episode of MS in childhood," they concluded.
The findings are published in the December issue of the journal Archives of Pediatrics & Adolescent Medicine.
More information
The American Academy of Family Physicians has more about hepatitis B. 
Copyright © 2007 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.